Oriola
0,89
EUR
-0,56 %
Corporate customer
OKDBV
NASDAQ Helsinki
Medical Equipment & Services
Health Care
7.643 investorer følger denne virksomhed
-0,56%
+1,6%
-3,78%
-1,55%
-18,2%
-18,2%
-56,27%
-56,05%
-51,61%
Oriola is a pharmaceutical group with a special focus on the distribution of pharmaceuticals to other companies in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest presence is in the Nordic and Baltic countries. The head office is located in Espoo.
Læs mereMarkedsværdi
161,52 mio. EUR
Aktieomsætning
310,14 t EUR
P/E (adj.) (24e)
23,76
EV/EBIT (adj.) (24e)
3,73
P/B (24e)
1,02
EV/S (24e)
0,05
Udbytteafkast, % (24e)
8,99 %
Coverage
Finanskalender
4.3
2025
Årsrapport '24
2.4
2025
Generalforsamling '24
29.4
2025
Delårsrapport Q1'25
Risiko
Business risk
Valuation risk
Lav
Høj
ViserAlle indholdstyper
Oriola Oyj: Oriola renews operating model and management team to accelerate strategy execution
Oriola Oyj: The Swedish Patent and Market Court rejected Apotekstjänst Sverige AB's appeal regarding the sale of Svensk dos AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools